Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 18 studies | 27% ± 10% | |
oligodendrocyte | 11 studies | 30% ± 13% | |
glutamatergic neuron | 10 studies | 45% ± 25% | |
GABAergic neuron | 9 studies | 44% ± 25% | |
oligodendrocyte precursor cell | 9 studies | 32% ± 13% | |
astrocyte | 9 studies | 31% ± 14% | |
fibroblast | 8 studies | 22% ± 5% | |
adipocyte | 8 studies | 24% ± 6% | |
microglial cell | 7 studies | 27% ± 7% | |
ciliated cell | 7 studies | 22% ± 7% | |
interneuron | 6 studies | 48% ± 26% | |
macrophage | 6 studies | 32% ± 4% | |
retina horizontal cell | 6 studies | 20% ± 5% | |
neuron | 5 studies | 30% ± 13% | |
retinal bipolar neuron | 5 studies | 21% ± 3% | |
epithelial cell | 5 studies | 36% ± 13% | |
basal cell | 5 studies | 28% ± 17% | |
amacrine cell | 5 studies | 21% ± 4% | |
pericyte | 5 studies | 21% ± 6% | |
endothelial cell of lymphatic vessel | 5 studies | 24% ± 4% | |
club cell | 5 studies | 19% ± 4% | |
smooth muscle cell | 5 studies | 20% ± 1% | |
type I pneumocyte | 5 studies | 24% ± 5% | |
type II pneumocyte | 5 studies | 23% ± 6% | |
granule cell | 4 studies | 25% ± 5% | |
cardiac muscle cell | 4 studies | 19% ± 2% | |
myeloid cell | 4 studies | 20% ± 5% | |
GABAergic interneuron | 3 studies | 34% ± 1% | |
retinal ganglion cell | 3 studies | 30% ± 3% | |
plasma cell | 3 studies | 17% ± 2% | |
retinal cone cell | 3 studies | 21% ± 5% | |
dendritic cell | 3 studies | 16% ± 0% | |
mesothelial cell | 3 studies | 22% ± 4% | |
lymphocyte | 3 studies | 21% ± 4% | |
GABAergic amacrine cell | 3 studies | 23% ± 5% | |
Mueller cell | 3 studies | 20% ± 2% | |
OFF-bipolar cell | 3 studies | 21% ± 4% | |
ON-bipolar cell | 3 studies | 25% ± 2% | |
glycinergic amacrine cell | 3 studies | 21% ± 0% | |
rod bipolar cell | 3 studies | 26% ± 4% | |
hepatocyte | 3 studies | 25% ± 10% | |
T cell | 3 studies | 16% ± 1% | |
alveolar macrophage | 3 studies | 22% ± 7% | |
monocyte | 3 studies | 21% ± 4% | |
transit amplifying cell | 3 studies | 35% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2919.50 | 1445 / 1445 | 100% | 18.14 | 183 / 183 |
prostate | 100% | 2363.88 | 245 / 245 | 99% | 13.95 | 499 / 502 |
breast | 100% | 2318.73 | 459 / 459 | 99% | 18.61 | 1111 / 1118 |
lung | 100% | 2404.90 | 578 / 578 | 99% | 13.12 | 1147 / 1155 |
brain | 99% | 2117.14 | 2625 / 2642 | 99% | 11.89 | 699 / 705 |
ovary | 100% | 2350.14 | 180 / 180 | 98% | 9.96 | 422 / 430 |
pancreas | 99% | 1247.86 | 326 / 328 | 98% | 11.64 | 175 / 178 |
uterus | 100% | 3028.06 | 170 / 170 | 98% | 11.13 | 448 / 459 |
intestine | 100% | 2315.28 | 966 / 966 | 97% | 11.42 | 513 / 527 |
stomach | 100% | 2077.98 | 359 / 359 | 97% | 12.90 | 278 / 286 |
thymus | 100% | 2796.97 | 653 / 653 | 97% | 12.75 | 588 / 605 |
adrenal gland | 100% | 2373.00 | 258 / 258 | 97% | 11.91 | 223 / 230 |
kidney | 100% | 1565.39 | 89 / 89 | 95% | 11.18 | 858 / 901 |
bladder | 100% | 2498.24 | 21 / 21 | 95% | 9.86 | 478 / 504 |
skin | 100% | 2293.32 | 1809 / 1809 | 92% | 11.36 | 432 / 472 |
liver | 100% | 1068.23 | 226 / 226 | 78% | 5.05 | 316 / 406 |
adipose | 100% | 2466.17 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2606.01 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2928.99 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1659.15 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.73 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 98% | 13.37 | 44 / 45 |
heart | 97% | 1889.04 | 832 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 69% | 5.45 | 55 / 80 |
lymph node | 0% | 0 | 0 / 0 | 59% | 2.85 | 17 / 29 |
peripheral blood | 35% | 479.43 | 322 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0050796 | Biological process | regulation of insulin secretion |
GO_2000074 | Biological process | regulation of type B pancreatic cell development |
GO_0007283 | Biological process | spermatogenesis |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0007165 | Biological process | signal transduction |
GO_2000323 | Biological process | negative regulation of glucocorticoid receptor signaling pathway |
GO_0006338 | Biological process | chromatin remodeling |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0007623 | Biological process | circadian rhythm |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0051775 | Biological process | response to redox state |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0042753 | Biological process | positive regulation of circadian rhythm |
GO_0009648 | Biological process | photoperiodism |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0042634 | Biological process | regulation of hair cycle |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0006473 | Biological process | protein acetylation |
GO_0071479 | Biological process | cellular response to ionizing radiation |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0000077 | Biological process | DNA damage checkpoint signaling |
GO_0005654 | Cellular component | nucleoplasm |
GO_0033391 | Cellular component | chromatoid body |
GO_0005829 | Cellular component | cytosol |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_1990513 | Cellular component | CLOCK-BMAL transcription complex |
GO_0005694 | Cellular component | chromosome |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0031490 | Molecular function | chromatin DNA binding |
GO_0004402 | Molecular function | histone acetyltransferase activity |
GO_0070888 | Molecular function | E-box binding |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CLOCK |
Protein name | Circadian locomoter output cycles protein kaput (hCLOCK) (EC 2.3.1.48) (Class E basic helix-loop-helix protein 8) (bHLHe8) Circadian locomoter output cycles protein kaput (EC 2.3.1.48) |
Synonyms | KIAA0334 BHLHE8 |
Description | FUNCTION: Transcriptional activator which forms a core component of the circadian clock. The circadian clock, an internal time-keeping system, regulates various physiological processes through the generation of approximately 24 hour circadian rhythms in gene expression, which are translated into rhythms in metabolism and behavior. It is derived from the Latin roots 'circa' (about) and 'diem' (day) and acts as an important regulator of a wide array of physiological functions including metabolism, sleep, body temperature, blood pressure, endocrine, immune, cardiovascular, and renal function. Consists of two major components: the central clock, residing in the suprachiasmatic nucleus (SCN) of the brain, and the peripheral clocks that are present in nearly every tissue and organ system. Both the central and peripheral clocks can be reset by environmental cues, also known as Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the central clock is light, which is sensed by retina and signals directly to the SCN. The central clock entrains the peripheral clocks through neuronal and hormonal signals, body temperature and feeding-related cues, aligning all clocks with the external light/dark cycle. Circadian rhythms allow an organism to achieve temporal homeostasis with its environment at the molecular level by regulating gene expression to create a peak of protein expression once every 24 hours to control when a particular physiological process is most active with respect to the solar day. Transcription and translation of core clock components (CLOCK, NPAS2, BMAL1, BMAL2, PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm generation, whereas delays imposed by post-translational modifications (PTMs) are important for determining the period (tau) of the rhythms (tau refers to the period of a rhythm and is the length, in time, of one complete cycle). A diurnal rhythm is synchronized with the day/night cycle, while the ultradian and infradian rhythms have a period shorter and longer than 24 hours, respectively. Disruptions in the circadian rhythms contribute to the pathology of cardiovascular diseases, cancer, metabolic syndromes and aging. A transcription/translation feedback loop (TTFL) forms the core of the molecular circadian clock mechanism. Transcription factors, CLOCK or NPAS2 and BMAL1 or BMAL2, form the positive limb of the feedback loop, act in the form of a heterodimer and activate the transcription of core clock genes and clock-controlled genes (involved in key metabolic processes), harboring E-box elements (5'-CACGTG-3') within their promoters. The core clock genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form the negative limb of the feedback loop and interact with the CLOCK|NPAS2-BMAL1|BMAL2 heterodimer inhibiting its activity and thereby negatively regulating their own expression. This heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G, which form a second feedback loop and which activate and repress BMAL1 transcription, respectively. Regulates the circadian expression of ICAM1, VCAM1, CCL2, THPO and MPL and also acts as an enhancer of the transactivation potential of NF-kappaB. Plays an important role in the homeostatic regulation of sleep. The CLOCK-BMAL1 heterodimer regulates the circadian expression of SERPINE1/PAI1, VWF, B3, CCRN4L/NOC, NAMPT, DBP, MYOD1, PPARGC1A, PPARGC1B, SIRT1, GYS2, F7, NGFR, GNRHR, BHLHE40/DEC1, ATF4, MTA1, KLF10 and also genes implicated in glucose and lipid metabolism. Promotes rhythmic chromatin opening, regulating the DNA accessibility of other transcription factors. The CLOCK-BMAL2 heterodimer activates the transcription of SERPINE1/PAI1 and BHLHE40/DEC1. The preferred binding motif for the CLOCK-BMAL1 heterodimer is 5'-CACGTGA-3', which contains a flanking adenine nucleotide at the 3-prime end of the canonical 6-nucleotide E-box sequence . CLOCK specifically binds to the half-site 5'-CAC-3', while BMAL1 binds to the half-site 5'-GTGA-3' . The CLOCK-BMAL1 heterodimer also recognizes the non-canonical E-box motifs 5'-AACGTGA-3' and 5'-CATGTGA-3' . CLOCK has an intrinsic acetyltransferase activity, which enables circadian chromatin remodeling by acetylating histones and nonhistone proteins, including its own partner BMAL1. Represses glucocorticoid receptor NR3C1/GR-induced transcriptional activity by reducing the association of NR3C1/GR to glucocorticoid response elements (GREs) via the acetylation of multiple lysine residues located in its hinge region . The acetyltransferase activity of CLOCK is as important as its transcription activity in circadian control. Acetylates metabolic enzymes IMPDH2 and NDUFA9 in a circadian manner. Facilitated by BMAL1, rhythmically interacts and acetylates argininosuccinate synthase 1 (ASS1) leading to enzymatic inhibition of ASS1 as well as the circadian oscillation of arginine biosynthesis and subsequent ureagenesis . Drives the circadian rhythm of blood pressure through transcriptional activation of ATP1B1 (By similarity). . |
Accessions | ENST00000309964.8 O15516 Q3ZCT4 ENST00000435527.6 ENST00000381322.5 ENST00000513440.6 C9JK03 |